BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BMS-986484 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BMS-986484\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06544655-2408@assetmemo.bio
DTSTAMP:20261121T005417Z
DTSTART;VALUE=DATE:20271014
DTEND;VALUE=DATE:20271015
SUMMARY:BMS-986484: Phase 1 readout est. (NCT06544655)
DESCRIPTION:BMS-986484\, phase 1.\nStudy: A Study of BMS-986484 Alone and C
 ombination Therapy in Participants With Advanced Solid Tumors\nEstimated p
 rimary completion: 14 October 2027. This is a ClinicalTrials.gov estimate\
 , not a confirmed readout date\, and it can move.\nDrug page: https://asse
 tmemo.bio/drug/bms-986484#upcoming-events\nRegistry record: https://clinic
 altrials.gov/study/NCT06544655
URL:https://assetmemo.bio/drug/bms-986484#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
